Comparing Asthma Control among Children between 5-18 Years of Age – GINA-2017 based Questionnaire

Published On: 11 Sep, 2023 12:00 PM | Updated On: 21 May, 2024 8:04 PM

Comparing Asthma Control among Children between 5-18 Years of Age – GINA-2017 based Questionnaire

A recent study aimed to assess asthma control in children in the age-range 5-18 years. The study compared the Asthma Control Test (ACT)/Childhood Asthma Control Test (cACT) Questionnaire, as outlined in the Global Initiative for Asthma 2017 (GINA-2017), against spirometry.

This was a prospective observational study conducted in the pulmonology Outpatient Department (OPD) of a tertiary care center from 2017-2019. Children between 5-18, meeting the inclusion criteria and diagnosed with asthma, underwent spirometry and the cACT/ACT questionnaire before commencing inhaled corticosteroid treatment. After 12 weeks, symptom control was reassessed using both ACT/cACT and spirometry. Qualitative and quantitative data were analyzed.

It was noted that the pretreatment score for ACT/cACT was 12.76 (2.521), which increased to 23.94 (1.941) at follow-up. According to the GINA guidelines, the proportion of patients with control rose from 2.04% to 91.84% at follow-up. Significant improvements were attained in the forced expiratory volume in the first second (FEV1), forced expiratory volume/forced vital capacity (FEV1/FVC), forced expiratory flow between 25 and 75% of FVC (FEF25−75), and peak expiratory flow rate (PEFR) – between pretreatment and follow-up. The percentage changes were − 71.86%, 106.84%, 101.82%, and 97.51%, respectively (versus 82.2%, 109.55%, 110.38%, and 107.00%). Additionally, a positive correlation existed between ACT/cACT and FEV1, as well as PEFR.

The results suggested a strong correlation between symptom control as assessed by ACT/cACT and spirometry, with a notably positive correlation observed for FEV1 and PEFR.

Source: NC G, K N. Indian Journal of Pediatrics. 2023 Aug;90(8):770-5.

user
IJCP Editorial Team

Comprising seasoned professionals and experts from the medical field, the IJCP editorial team is dedicated to delivering timely and accurate content and thriving to provide attention-grabbing information for the readers. What sets them apart are their diverse expertise, spanning academia, research, and clinical practice, and their dedication to upholding the highest standards of quality and integrity. With a wealth of experience and a commitment to excellence, the IJCP editorial team strives to provide valuable perspectives, the latest trends, and in-depth analyses across various medical domains, all in a way that keeps you interested and engaged.

 More FAQs by IJCP Editorial Team
Logo

Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks